Not all tissues age the same. Discover how asynchronous aging insights are reshaping healthspan science with precision therapies for longer, healthier lives.
Uncovering cancer-associated fibroblasts: the hidden architects of ovarian cancer’s defenses and the potential targets for overcoming treatment resistance.
Cutting-edge research in gene therapy, light therapy, and AI is redefining how we understand and treat Age-Related Macular Degeneration, offering hope for lasting vision.
Caloric restriction mimetics offer the benefits of calorie reduction without extreme diets, targeting pathways linked to aging for a longer, healthier life.
NLRC5 drives inflammatory cell death in diseases like colitis. Targeting NAD+ or inhibiting NLRC5 could offer promising treatments, reducing inflammation.
Nanopore protein sequencing offers groundbreaking insights into how proteins age, driving advancements in longevity research and unlocking potential therapies for age-related diseases.
Cellular reprogramming holds the promise of reversing aging by resetting cells to a youthful state. Advances in this science could revolutionize longevity and healthspan.
RESTORIN activates key longevity pathways like DNA repair, mTOR inhibition, and cognitive support, offering a scientifically-backed approach to extending healthspan.
As breast cancer treatment advances, scientists are focusing on how aging impacts survivorship, treatments, and long-term quality of life for older women.
Scientists are unlocking the secrets of aging, aiming to extend healthy human lifespan through groundbreaking research in senolytics, metformin, and gene editing technologies.